This research investigates how IDH-mutant gliomas transform from slow-growing tumors into aggressive, fatal malignancies. By comparing single-cell gene expression and chromatin accessibility, the authors found that these tumors start as indolent cells resembling oligodendrocyte progenitors (OPCs) fueled by epigenetic changes like DNA hypermethylation. As the disease progresses, the tumors shift toward a proliferative state resembling neural progenitor cells (NPCs) that share a similar epigenetic landscape but enact different genetic programs. This transition is marked by a loss of global DNA methylation, forcing the cancer to acquire new genetic mutations to maintain growth and suppress immune responses. Specifically, the study highlights how interferon signaling is initially silenced by methylation in low-grade cases but is later disrupted by genetic deletions in high-grade cases. These insights suggest that targeting epigenetic mechanisms may be most effective early in the disease before genetic alterations become the primary drivers.

References:

• Wu J, Gonzalez Castro L N, Battaglia S, et al. Evolving cell states and oncogenic drivers during the progression of IDH-mutant gliomas[J]. Nature Cancer, 2025, 6(1): 145-157.